PRENATAL VITAMIN PLUS LOW IRON (prenatal vits with calcium no.72/ferrous fumarate/folic acid)
FOLIC ACID · PREGNANCY ·+1
NNODUM CORP
Drug class
Iron
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products. Read more about Iron
368 drugs in this class 107 manufacturers
Drugs in Iron
PRENATAL MULTI-DHA (prenatal vitamins no.40/ferrous fumarate/folic acid/dha)
FOLIC ACID · PREGNANCY ·+1
CVS
PRENATAL ONE DAILY (prenatal vit with calcium no.129/ferrous fumarate/folic acid)
FOLIC ACID · PREGNANCY ·+1
FREEDA VITAMINS
BLISOVI FE (norethindrone acetate-ethinyl estradiol/ferrous fumarate)
CONTRACEPTIVES · PREGNANCY CONTRACEPTION
LUPIN PHARMACEU
KAITLIB FE (norethindrone-ethinyl estradiol/ferrous fumarate)
CONTRACEPTIVES · PREGNANCY CONTRACEPTION
LUPIN PHARMACEU
NUFERA (iron,carbonyl/folate combo no.9/vit C/vit D3/vit B6/vit B12)
FOLIC ACID · VITAMIN DEFICIENCY ·+3
CARWIN ASSOCIAT
KOSHER PRENATAL PLUS IRON (prenatal vitamins no.108/iron,carbonyl/folic acid)
FOLIC ACID · PREGNANCY ·+1
NATIONWIDE LABO
FERROUS SULFATE
IRON · IRON DEFICIENCY ANEMIA
21ST CENTURY HE
ALLEGIS PHARMAC
Filter & compare in the drug finder →
Opens the drug finder with Iron preselected. Add indication or manufacturer filters there.
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products.
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body.
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand.
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure.
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
nih.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
fda.gov
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
fda.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
-
nih.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.